← Back to Search

Optical Lens

Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness (ASH-2 Trial)

N/A
Waitlist Available
Research Sponsored by SightGlass Vision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Are 8-14 years of age;
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes and 60 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial will test new lenses to see if they improve vision health.

Who is the study for?
This trial is for children aged 8-14 who can read or understand an assent document, have a parent or guardian to sign permission, and have near-sightedness within specific limits (+1.00D to -1.00D). They must be able to follow instructions.
What is being tested?
The study tests if DOT spectacle lenses affect the thickness and vascularity of the choroid (a part of the eye) compared to standard control lenses in children with near-sightedness.
What are the potential side effects?
Since this trial involves wearing special spectacle lenses, side effects may include discomfort while adjusting to new lenses, potential headaches or eye strain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 8 and 14 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes and 60 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes and 60 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Choroiditis
Retinal and Choroidal Thickness
Secondary study objectives
Software Method Comparison

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment 1 - Diffusion Optics Technology (DOT) PatternExperimental Treatment1 Intervention
Group II: Treatment 2 - Control SpectaclesActive Control1 Intervention

Find a Location

Who is running the clinical trial?

SightGlass Vision, Inc.Lead Sponsor
10 Previous Clinical Trials
1,063 Total Patients Enrolled
University of WaterlooOTHER
127 Previous Clinical Trials
214,796 Total Patients Enrolled
~10 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top